Related Experiment Videos
Carbohydrate-lectin interactions assessed by surface plasmon resonance
Eric Duverger1, Natacha Frison, Annie-Claude Roche
1Glycobiologie, Vectorologie et Trafic intracellulaire, Centre de Biophysique Moléculaire, CNRS, 1, rue Charles-Sadron, 45071 Orléans cedex 2, France.
Biochimie
|May 27, 2003
Summary
Surface Plasmon Resonance (SPR) is a powerful technique for studying sugar-protein interactions, providing insights into specificity, kinetics, and thermodynamics. This guide details SPR principles, data analysis, and common challenges for accurate sugar-lectin interaction studies.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Biophysics
Background:
- Sugar-protein interactions are crucial in biological processes.
- Surface Plasmon Resonance (SPR) offers a label-free method to study these interactions.
- Understanding these interactions is key for developing medical applications.
Purpose of the Study:
- To present theoretical and practical considerations for using SPR to study sugar-protein interactions.
- To discuss data analysis methods and potential challenges in SPR experiments.
- To highlight the utility of SPR in characterizing lectin-sugar specificity and aiding medical tool development.
Main Methods:
- Surface Plasmon Resonance (SPR) principle and application.
- Data analysis using Langmuir, Scatchard, fractal, and Sips models.
- Addressing limitations such as mass transport, ligand heterogeneity, and non-linearity.
Main Results:
- SPR effectively assesses specificity, strength, kinetics, and thermodynamics of sugar-protein binding.
- Fractal and Sips approaches can linearize non-linear SPR data caused by cluster effects.
- Summarized data illustrate SPR's use with immobilized carbohydrates or lectins.
Conclusions:
- SPR is a versatile tool for detailed analysis of sugar-lectin interactions.
- Addressing experimental challenges like non-linearity is crucial for accurate SPR data interpretation.
- SPR contributes to understanding oligosaccharide structure, lectin specificity, and developing medical applications.